Genistein down-modulates pro-inflammatory cytokines and reverses clinical signs of experimental autoimmune encephalomyelitis

International Immunopharmacology

Volumn 8, Issue 9, 2008, Pages 1291-1297

  De Paula, Marcio L ^a   Rodrigues, David H ^b   Teixeira, Henrique C ^a   Barsante, Michele M ^a   Souza, Maria A ^a   Ferreira, Ana P ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Cytokines; Experimental autoimmune encephalomyelitis; Genistein; Intravital microscopy; Multiple sclerosis

Indexed keywords

CD4 ANTIGEN; CYTOKINE; GAMMA INTERFERON; GENISTEIN; INTERLEUKIN 10; INTERLEUKIN 12; MYELIN OLIGODENDROCYTE GLYCOPROTEIN; MYELIN OLIGODENDROCYTE GLYCOPROTEIN[35-55]; TUMOR NECROSIS FACTOR ALPHA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; FEMALE; IMAGE ANALYSIS; INTRAVITAL MICROSCOPY; LEUKOCYTE ADHERENCE; LEUKOCYTE ROLLING; MICROSCOPY; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; SYMPTOM; TH1 CELL;

ANIMALS; ANTICARCINOGENIC AGENTS; CELLS, CULTURED; CYTOKINES; DOWN-REGULATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GENISTEIN; GLYCOPROTEINS; INTERLEUKIN-10; LEUKOCYTES; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; SPLEEN; UP-REGULATION;

EID: 46349083371     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.05.002     Document Type: Article

References (36)

1. Weiner H.L., and Selkoe D.J. Inflammation and therapeutic vaccination in CNS diseases. Nature 420 (2002) 879-884
2. Steinman L., and Zamvil S. Transcriptional analysis of targets in multiple sclerosis. Nat Rev Immunol 3 (2003) 483-492
3. Dyment D., Ebers G., and Sadovnick A.D. Genetics of multiple sclerosis. Lancet Neurol 3 (2004) 104-110
4. Begolka W.S., and Miller S.D. Cytokines as intrinsic and exogenous regulators of pathogenesis in experimental autoimmune encephalomyelitis. Res Immunol 149 (1998) 771-781
5. Sospedra M., and Martin R. Immunology of multiple sclerosis. Annu Rev Immunol 23 (2005) 683-747
6. Kuiper G.G.J.M., Lemmen J.G., Carlsson B., Corton J.C., Safe S.H., van der Saag P.T., et al. Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor {beta}. Endocrinology 139 (1998) 4252-4263
7. Bhathena S.J., and Velasquez M.T. Beneficial role of dietary phytoestrogens in obesity and diabetes. Am J Clin Nutr 76 (2002) 1191-1201
8. Lamartiniere C.A., Cotroneo M.S., Fritz W.A., Wang J., Mentor-Marcel R., and Elgavish A. Genistein chemoprevention: timing and mechanisms of action in murine mammary and prostate. J Nutr 132 (2002) 552S-555S
9. Tham D.M., Gardner C.D., and Haskell W.L. Potential health benefits of dietary phytoestrogens: a review of the clinical, epidemiological, and mechanistic evidence. J Clin Endocrinol Metab 83 (1998) 2223-2235
10. Wei H., Bowen R., Cai Q., Barnes S., and Wang Y. Antioxidant and antipromotional effects of the soybean isoflavone genistein. Proc Soc Exp Biol Med 208 (1995) 124-130
11. Polkowski K., and Mazurek A.P. Biological properties of genistein. A review of in vitro and in vivo data. Acta Pol Pharm 57 (2000) 135-155
12. Yellayi S., Naaz A., Szewczykowski M.A., Sato T., Woods J.A., Chang J., et al. The phytoestrogen genistein induces thymic and immune changes: a human health concern?. Proc Natl Acad Sci USA 99 (2002) 7616-7621
13. Carvalho-Tavares J., Hickey M.J., Hutchison J., Michaud J., Sutcliffe I.T., and Kubes P. A role for platelets and endothelial selectins in tumor necrosis factor-{alpha}-induced leukocyte recruitment in the brain microvasculature. Circ Res 87 (2000) 1141-1148
14. Leadbetter E.A., Bourque C.R., Devaux B., Olson C.D., Sunshine G.H., Hirani S., et al. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide. J Immunol 161 (1998) 504-512
15. Hendriks J.J.A., Alblas J., van der Pol S.M.A., van Tol E.A.F., Dijkstra C.D., and de Vries H.E. Flavonoids influence monocytic GTPase activity and are protective in experimental allergic encephalitis. J Exp Med 200 (2004) 1667-1672
16. Muthian G., and Bright J.J. Quercetin, a flavonoid phytoestrogen, ameliorates experimental allergic encephalomyelitis by blocking IL-12 signaling through JAK-STAT pathway in T lymphocyte. J Clin Immunol 24 (2004) 542-552
17. Singh N.P., Hegde V., Hofseth L.J., Nagarkatti M., and Nagarkatti P. Resveratrol (trans-3, 5,4′-trihydroxystilbene) ameliorates experimental allergic encephalomyelitis primarily via induction of apoptosis in T cells involving activation of aryl hydrocarbon receptor and estrogen receptor. Mol Pharmacol 72 (2007) 1508-1521
18. Gossner G., Choi M., Tan L., Fogoros S., Griffith K.A., and Kuenker M. Genistein-induced apoptosis and autophagocytosis in ovarian cancer cells. Gynecol Oncol. 105 (2007) 23-30
19. Platten M., and Steinman L. Multiple sclerosis: trapped in deadly glue. Nat Med 11 (2005) 252-253
20. Willenborg D.O., Fordham S.A., Staykova M.A., Ramshaw I.A., and Cowden W.B. IFN- {gamma} is critical to the control of murine autoimmune encephalomyelitis and regulates both in the periphery and in the target tissue: a possible role for nitric oxide. J Immunol 163 (1999) 5278-5286
21. Takeuchi H., Wang J., Kawanokuchi J., Mitsuma N., Mizuno T., and Suzumura A. Interferon-gamma induces microglial-activation-induced cell death: a hypothetical mechanism of relapse and remission in multiple sclerosis. Neurobiol Dis 22 (2006) 33-39
22. Xiao B.G., Ma C.G., Xu L.Y., Link H., and Lu C.Z. IL-12/IFN-gamma/NO axis plays critical role in development of Th1-mediated experimental autoimmune encephalomyelitis. Mol Immunol 45 (2008) 1191-1196
23. Leonard J.P., Waldburger K.E., and Goldman S.J. Prevention of experimental autoimmune encephalomyelitis by antibodies against interleukin 12. J Exp Med 181 (1995) 381-386
24. Zhang G.X., Gran B., Yu S., Li J., Siglienti I., Chen X., et al. Induction of experimental autoimmune encephalomyelitis in IL-12 receptor-{beta}2-deficient mice: IL-12 responsiveness is not required in the pathogenesis of inflammatory demyelination in the central nervous system. J Immunol 170 (2003) 2153-2160
25. Ozenci V., Kouwenhoven M., Huang Y.M., Kivisakk P., and Link H. Multiple sclerosis is associated with an imbalance between tumour necrosis factor-alpha (TNF-alpha)- and IL-10-secreting blood cells that is corrected by interferon-beta (IFN-beta) treatment. Clin Exp Immunol 120 (2000) 147-153
26. Juedes A.E., Hjelmström P., Bergman C.M., Neild A.L., and Ruddle N.H. Kinetics and cellular origin of cytokines in the central nervous system: insight into mechanisms of myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis. J Immunol 164 (2000) 419-426
27. McGeachy M.J., and Anderton S.M. Cytokines in the induction and resolution of experimental autoimmune encephalomyelitis. Cytokine 32 (2005) 81-84
28. Bettelli E., Prabhu Das M., Howard E.D., Weiner H.L., Sobel R.A., and Kuchroo V.K. IL-10 is critical in the regulation of autoimmune encephalomyelitis as demonstrated by studies of IL-10- and IL-4-deficient and transgenic mice. J Immunol 161 (1998) 3299-3306
29. Bettelli E., Nicholson L.B., and Kuchroo V.K. IL-10, a key effector regulatory cytokine in experimental autoimmune encephalomyelitis. J Autoimmun 20 (2003) 265-267
30. Segal B.M., Dwyer B.K., and Shevach E.M. An interleukin (IL)-10/IL-12 immunoregulatory circuit controls susceptibility to autoimmune disease. J Exp Med 187 (1998) 537-546
31. Ransohoff R.M., Kivisakk P., and Kidd G. Three or more routes for leukocyte migration into the central nervous system. Nat Rev Immunol 3 (2003) 569-581
32. Kerfoot S.M., and Kubes P. Overlapping roles of P-selectin and {alpha} 4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis. J Immunol 169 (2002) 1000-1006
33. Sorensen T.L., Tani M., Jensen J., Pierce V., Lucchinetti C., Folcik V.A., et al. Expression of specific chemokines and chemokine receptors in the central nervous system of multiple sclerosis patients. J Clin Invest 103 (1999) 807-815
34. Glass W.G., Hickey M.J., Hardison J.L., Liu M.T., Manning J.E., and Lane T.E. Antibody targeting of the CC Chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 172 (2004) 4018-4025
35. Kuiper G.G.J.M., Carlsson B., Grandien K., Enmark E., Haggblad J., Nilsson S., et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors {alpha} and {beta}. Endocrinology 138 (1997) 863-870
36. Muller D.M., Pender M.P., and Greer J.M. Chemokines and chemokine receptors: potential therapeutic targets in multiple sclerosis. Curr Drug Targets Inflamm Allergy 3 (2004) 279-290